Study

EORTC-21081

A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 26-Jul-2010
Date Step1 close: 02-Sep-2013
Date Step2 close: 27-Mar-2013

Data management at EORTC

Yes

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 105 - All Groups: 105

Protocol summary

http://clinicaltrials.gov/study/NCT01098656

NCT number

NCT01098656

EudraCT

2009-011020-65